Bryan Xie, PhD

Bryan joined LifeSci in June 2024 with academic and industry experience. He received his PhD in Immunology in 2021 where he researched cell therapy approaches for immune regulation in autoimmunity and allogeneic hematopoietic stem cell transplantation. In addition, while in graduate school, he helped spun out a company (Triursus Therapeutics) from his advisor’s lab and received $2 million in NIH SBIR grant funding, co-founded an educational public biotech equity investment fund (Mythos Biotechnology Fund), and consulted for Biotech Connection Bay Area in a market assessment and customer discovery engagement. After graduating, he worked as a target discovery scientist and business development associate at 3T Biosciences, and recently as a business development manager at UC Irvine Center for Clinical Research. Bryan received his PhD from Stanford Medicine and his BS in Molecular Biology & Biochemistry from UC Irvine.